532878 Stock Overview
Engages in the manufacture and sale of pharmaceutical finished dosage forms in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Alpa Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹114.95 |
| 52 Week High | ₹144.60 |
| 52 Week Low | ₹71.00 |
| Beta | 1.04 |
| 11 Month Change | -3.00% |
| 3 Month Change | 10.04% |
| 1 Year Change | 19.69% |
| 33 Year Change | 122.13% |
| 5 Year Change | 626.61% |
| Change since IPO | 109.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532878 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.3% | -1.8% | -1.8% |
| 1Y | 19.7% | 41.2% | 27.2% |
Return vs Industry: 532878 underperformed the Indian Pharmaceuticals industry which returned 41.1% over the past year.
Return vs Market: 532878 underperformed the Indian Market which returned 27% over the past year.
Price Volatility
| 532878 volatility | |
|---|---|
| 532878 Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532878's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 532878's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 410 | Paresh Chawla | www.alpalabs.in |
Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations.
Alpa Laboratories Limited Fundamentals Summary
| 532878 fundamental statistics | |
|---|---|
| Market cap | ₹2.35b |
| Earnings (TTM) | ₹162.42m |
| Revenue (TTM) | ₹1.09b |
14.5x
P/E Ratio2.2x
P/S RatioIs 532878 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532878 income statement (TTM) | |
|---|---|
| Revenue | ₹1.09b |
| Cost of Revenue | ₹743.54m |
| Gross Profit | ₹343.85m |
| Other Expenses | ₹181.43m |
| Earnings | ₹162.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.72 |
| Gross Margin | 31.62% |
| Net Profit Margin | 14.94% |
| Debt/Equity Ratio | 3.5% |
How did 532878 perform over the long term?
See historical performance and comparison